Chelsfield Park Hospital 01689 877855 Blackheath Hospital 020 8003 6148 King Edward VII Hospital 02074674344 alison.hagerty@hotmail.com

Arthrosamid® is a next-generation hydrogel injection designed to relieve pain and improve function in patients with knee osteoarthritis. It works by enhancing the joint’s cushioning and reducing inflammation.

This non-surgical option is ideal for individuals looking to delay or avoid knee replacement surgery.

Key Benefits:

  • Minimally invasive

  • Long-term symptom control

  • Suitable for mild to moderate OA

Introducing Arthrosamid® 

 Arthrosamid® is a non-biodegradable injectable polyacrylamide hydrogel (2.5% iPAAG) implant consisting of 2.5% cross-linked polyacrylamide and 97.5% water. It is administered via a simple, one-step procedure performed under local anaesthesia by a qualified physician, such as an orthopaedic surgeon or rheumatologist1 — ensuring you’re in and out of the clinic the same day. Arthrosamid® is proven to maintain a significant, long-lasting reduction in knee OA pain2,3— even five years post-treatment.2 

 How does Arthrosamid® work? 

Arthrosamid® is the first and only permanent injectable implant that integrates with the knee’s synovial tissue,4 forming a scaffold that softens and increases tissue elasticity. This leads to decreased joint stiffness, reduced pain, and improved knee function.5,6,7 

 

Proven Results 

  • Over 20 years of research and development.
  • Safe and effective6,8 for its intended use, even five years post-treatment.
  • Around 1,200,000 syringes of 2.5% iPAAG have been made for human use.

Get in touch

Use our online booking form to request an appointment at any one of our three locations. My private secretary will contact you to confirm the appointment.

Contact us